Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24632
Abstract: Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for colorectal peritoneal carcinomatosis (PC) may negatively affect survival. The objective was to determine the impact of postoperative complications (CX) on survival in patients undergoing CRS + HIPEC… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27122
Abstract: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is an effective surgical intervention for peritoneal surface malignancy. The effect of myometrium invasion on outcomes is unknown. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27143
Abstract: We aim to assess the quality and readability of online information available to patients considering cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC). read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Abdominal Radiology"
DOI: 10.1007/s00261-018-1675-0
Abstract: PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): methodological issues on diagnostic value and reliability Siamak Sabour , Saeid Fallah, and Sajjad Rahimi Pordanjani Department of Clinical Epidemiology, School of Public… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Surgery Today"
DOI: 10.1007/s00595-020-02180-7
Abstract: The prognosis of peritoneal carcinomatosis is poor. However, the emergence of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) as a treatment option has prolonged survival and it can even potentially cure patients with peritoneal carcinomatosis.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-019-04463-y
Abstract: Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) results in significant morbidity and readmissions. Previous studies have been limited by single-institution design or lack of tumor details in the database used. Methods The 12-institution US… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "American journal of surgery"
DOI: 10.1016/j.amjsurg.2020.08.041
Abstract: INTRODUCTION Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an effective, aggressive approach to treating intraperitoneal carcinomatosis. This study aimed to test the efficacy/safety of an enhanced recovery (ERAS) program after CRS-HIPEC surgery. METHODS Review… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Acta Chirurgica Belgica"
DOI: 10.1080/00015458.2018.1436797
Abstract: Abstract Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is associated with significant manipulation of the urinary tract (UT). We aim to describe the urological events and their management in patients who underwent CRS-HIPEC. Methods:… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Vox Sanguinis"
DOI: 10.1111/vox.12546
Abstract: Perioperative red blood cell transfusions (PBT) may be associated with worse survival. In this study of adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC), we investigated whether there was an association between PBT and… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "World Journal of Surgical Oncology"
DOI: 10.1186/s12957-020-01898-5
Abstract: Background Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy. However, limited data exist on the utility of cytoreductive surgery and hyperthermic… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "A&A practice"
DOI: 10.1213/xaa.0000000000001643
Abstract: Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy is a complex and painful procedure that can cause postoperative hypotension and coagulopathy. Epidural analgesia may worsen hypotension and is contraindicated in the setting of coagulopathy. While alternative regional… read more here.